On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the federal agency indicates that the recalled medications could cause "temporary or medically reversible adverse health consequences," but that the chances of serious adverse health consequences are "remote."

Add it to the growing list of egg products recently flagged by the FDA. This time, however, a different bacteria concern is to blame.

ByHeart, which launched in 2021, is recalling batches of its “Whole Nutrition Infant Formula” because some of the product may be contaminated with Clostridium botulinum, the bacteria that cause infant botulism.

A company has recalled California-grown yellow and white peaches due to potential contamination with Listeria monocytogenes

Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.